Vanguard Personalized Indexing Management’s Puma Biotechnology PBYI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.4K	Buy	+10,408	New	+$76.2K	﹤0.01%	2074

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's PBYI Position: Q2 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 10,408 shares worth $84.4K. The stake represents ﹤0.01% of the portfolio and ranks #2074 among its holdings.

161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Vanguard Personalized Indexing Management held 10,408 shares of Puma Biotechnology worth $84.4K as of Q2 2026.
Puma Biotechnology was a new Vanguard Personalized Indexing Management position in Q2 2026.
Puma Biotechnology made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2074 holding.
161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.